CVA Family Office’s Lam Research LRCX Stock Holding History
Bought
Maintained
Sold
Other funds holding LRCX
CVA Family Office's LRCX Position: Q2 2026 in Review
CVA Family Office increased its Lam Research (LRCX) stake by 0.03% in Q2 2026, buying an estimated $607 and bringing the position to 6,496 shares worth $2.81M. The position accounts for 0.25% of the portfolio, ranked #64.
CVA Family Office first reported a position in LRCX in Q1 2021 and has held it in 21 quarters since. 3,146 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.
- CVA Family Office held 6,496 shares of Lam Research worth $2.81M as of Q2 2026.
- CVA Family Office bought 2 Lam Research shares in Q2 2026, an estimated $607.
- Lam Research made up 0.25% of CVA Family Office's portfolio in Q2 2026, its #64 holding.
- CVA Family Office first reported a position in Lam Research in Q1 2021 and has held it in 21 quarters since.
- 3,146 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.
Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.